Explores how personalised hormone therapy improves outcomes for menopausal women, suggesting a shift towards evidence-based care.
Prescribing of hormone therapy in menopause is moving away from strict limits towards individualised, evidence-based care. This article explores how optimising therapy, addressing risk and ensuring equitable access can improve outcomes for women in the UK
No takes yet. Share an insight, caveat, or question.
Aysha Mendes (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: